Division of Hematology
School of Medicine
2024 Hematology News
April 2024
Want a comprehensive overview of the FDA-approved CD19 #CART products & CD20 bispecifics available for #DLBCL and an insight into their optimal sequencing? Watch the wonderful interview with ():
ow.ly/YNcy50R7mwE
January 24. 2024
American Society of Clinical Oncology
HOT OFF THE PRESS 
Featured in #ASCODailyNews!!
*Dr. Cassandra Duarte and Dr. Ajay Major*
Understanding the Role of High-Dose Chemotherapy With ASCT Compared With CAR T-Cell Therapies in R/R LBCL
January 2024
Dr. Manali Kamdar was invited to chair the "How Do We Calibrate Cellular Therapy for Lymphoma in 2023?" Education Session @ the ASH 2023 Annual Meeting in San Diego, California.
She led the panel discussing cellular therapies such as CAR-T and bispecific antibodies. Important:
- These novel therapies are used to treat aggressive relapsed non-Hodgkin lymphomas.
- Anschutz Medical Campus is one of the only centers in this region of the United States to offer these novel therapies.
Featured Media | Rocky Mountain Region | Anschutz Medical Campus
Dr. Dan Pollyea
| 'Possibilities Endless' |
For appointments,
for referrals,
for consultations -
Hematology (SOM)
CU Anschutz
Research Complex II
12700 East 19th Avenue
Mail Stop B170
Aurora, CO 80045
Appointments: 720-848-6400
CMS Login